Here's Why BioMarin Pharmaceutical (BMRN) is a Strong Momentum StockZacks Investment Research • 02/24/26
Compared to Estimates, BioMarin (BMRN) Q4 Earnings: A Look at Key MetricsZacks Investment Research • 02/24/26
BioMarin Pharmaceutical (BMRN) Beats Q4 Earnings and Revenue EstimatesZacks Investment Research • 02/24/26
BioMarin Reports Fourth Quarter and Full-year 2025 Financial and Operating ResultsPRNewsWire • 02/23/26
Countdown to BioMarin (BMRN) Q4 Earnings: Wall Street Forecasts for Key MetricsZacks Investment Research • 02/19/26
BioMarin to Host Fourth Quarter and Full-Year 2025 Financial Results Conference Call and Webcast on Monday, February 23, 2026, at 4:30pm ETPRNewsWire • 02/17/26
What to Expect From These Drug/Biotech Players This Earnings Season?Zacks Investment Research • 02/16/26
Earnings Preview: BioMarin Pharmaceutical (BMRN) Q4 Earnings Expected to DeclineZacks Investment Research • 02/11/26
BioMarin Announces Pricing of Private Offering of Senior Notes and Completion of Syndication of New Senior Secured Term Loan FacilityPRNewsWire • 01/29/26
BioMarin Announces Proposed Private Offering of Senior Notes and Syndication of New Senior Secured Term Loan FacilityPRNewsWire • 01/26/26
Why BioMarin Pharmaceutical (BMRN) is a Top Momentum Stock for the Long-TermZacks Investment Research • 01/16/26
Here's Why BioMarin Pharmaceutical (BMRN) is a Strong Growth StockZacks Investment Research • 01/13/26
BioMarin Pharmaceutical Inc. (BMRN) Presents at 44th Annual J.P. Morgan Healthcare Conference TranscriptSeeking Alpha • 01/12/26
BioMarin to Present at the 44th Annual J.P. Morgan Healthcare Conference on Monday, January 12, at 11:15 am PT / 2:15 pm ET, in San Francisco, CAPRNewsWire • 01/08/26